Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Harvoni

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Harvoni was produced by Bristol-Myers Squibb.

Sovaldi-Daklinza combo cures hep C in co-infected HIV patients

Sovaldi-Daklinza combo cures hep C in co-infected HIV patients These include Gilead's Harvoni - which adds NS5A ledipasvir to sofosbuvir in a fixed-dose combination - and AbbVie's recently approved four drug regimen Viekirax (ombitasvir, paritaprevir and ritonavir) and Exviera ... Meanwhile, Gilead is also making

US lawmaker pushes for drug price transparency

US lawmaker pushes for drug price transparency Chiu says that Gilead's $1, 000 hep C pill Sovaldi (sofosbuvir), which costs $84, 000 for a regular course of treatment, and its follow-up Harvoni (sofosbuvir/ ledipasvir) that comes

Gilead agrees price cut for Sovaldi in Germany

Gilead agrees price cut for Sovaldi in Germany ledipasvir in Gilead's Harvoni product, which can be given without interferon and was approved in the EU last November. ... Meanwhile, Harvoni added another $2.1bn to Gilead's HCV franchise, despite only being approved for marketing last October in the US

ViiV maintains top spot in reputation survey

ViiV maintains top spot in reputation survey The reason for its slide, according to its analysis, is the firm's controversial pricing strategy for its new hepatitis C drugs Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir), given the

Gilead and Achillion see 100% success rate in hep C trial

Gilead and Achillion see 100% success rate in hep C trial This is currently the shortest duration and highest response achieved by any two-drug treatment for the disease, and beats Gilead's new combination therapy Harvoni (ledipasvir and sofosbuvir), which received ... far less than the $90, 000 plus price tag

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics